Gene hunt: can DNA clues unlock better prostate cancer care?
NCT ID NCT02705846
First seen Nov 01, 2025 · Last updated May 24, 2026 · Updated 23 times
Summary
This study follows over 4,000 men with prostate cancer, some who carry rare gene mutations (like BRCA) and some who don't. Researchers will compare survival and cancer progression between the groups using medical records and tumor samples. The goal is to learn how these genes affect treatment success, which could guide future care for men at higher genetic risk.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PROSTATE CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Institute of Cancer Research and Royal Marsden Hospital
RECRUITINGSutton, Surrey, SM2 5PT, United Kingdom
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.